Changes to Micronised Progesterone dosing in HRT

This page relates to a specific change in guidance. For more information about HRT, please see: www.nhs.uk/medicines/hormone-replacement-therapy-hrt/

A recent guideline from the British Menopause Society recommends increased doses of oral or vaginal micronised progesterone (brand name Utrogestan) when used as protection against endometrial cancer in HIGH dose HRT regimes. This is because there is an increased risk of endometrial thickening, changes and cancer in those on high dose oestrogen with inadequate progesterone dosing. The guidance can be found here

Please note this guidance does NOT apply to combined oestrogen and progesterone patches or tablets. It also does NOT apply to women who do not need progesterone because they have had a total abdominal hysterectomy.

The table below shows the levels of oestrogen that comprise different dosage regimes.

Dose

Ultra-Low

Low

Standard

Moderate

High

Oestrogel

½ pump

1 pump

2 pumps

3 pumps

4 pumps

Sandrena

0.25mg

0.5mg

1mg

1.5-2mg

3mg

Lenzetto Spray

1 spray

2 sprays

3 sprays

4-5 sprays

6 sprays

Patch

12.5 mcg

25mcg

50mcg

75mcg

100mcg

Oral estradiol

0.5mg

1mg

2mg

3mg

4mg

Anyone on a HIGH dose HRT regime using oral or vaginal micronized progesterone needs to be on an adequate dose, which is 200mg every night if taken continuously or 300mg for 12-14 days per month if taken sequentially. Please see table below:

 

Micronised Progesterone

Medroxy progesterone

Norethisterone

LNG-IUD (52mg)

Oestrogen dose

Cont.

Seq.

Cont.

Seq.

Cont.

Seq.

Up to 5 yrs – record fitting date on script

Ultra/Low

100mg

200mg

2.5mg

10mg

5mg

5mg

Standard

100mg

200mg

2.5-5mg

10mg

5mg

5mg

Moderate

100mg

200mg

5mg

10mg

5mg

5mg

High

200mg

300mg

10mg

20mg

5mg

5mg

Please be aware that there is currently no data to show whether the increased dose of micronized progesterone will affect your breast cancer risk, however under-dosing will definitely affect your endometrial cancer risk. If you are not comfortable increasing your micronised progesterone dose you may wish to consider a Mirena coil. If interested, please book a routine telephone appointment with Practice Nurses Sarah Senior or Rosie Humphries or GP Dr Lucy Bell to discuss this further.

People on MODERATE dose HRT regimes with oral or vaginal micronized progesterone who experience unscheduled bleeding should also be moved onto increased micronized progesterone and may need further investigation.

UNSCHEDULED BLEEDING is any bleeding on a continuous regime, or bleeding between periods on a sequential regime, that continues six months after starting HRT or three months after a dose change.  If you are experiencing unscheduled bleeding, please contact us via e-consultation directly.

Those on ULTRA-LOW/ LOW / STANDARD dose HRT regimes should also make contact via e-consultation if experiencing unscheduled bleeding. Otherwise please continue to attend annual HRT reviews with our Pharmacy team.